Trademark: 97261874
Word
TAKE2
Status
Registered
Status Code
700
Status Date
Tuesday, January 23, 2024
Serial Number
97261874
Registration Number
7283042
Registration Date
Tuesday, January 23, 2024
Mark Type
4000
Filing Date
Thursday, February 10, 2022
Published for Opposition
Tuesday, September 19, 2023

Trademark Owner History
Take2 Health Limited - Original Registrant

Classifications
9 (Based on 44(e)) Automated laboratory apparatus for use in analysis of biomolecules for scientific purposes; nucleic acid sequencers for scientific purposes; non-medical imaging devices for gemstones, roots, for clinical diagnostic purposes and scientific research; laboratory equipment, namely, cupels, funnels, microarrays, and electric bath heaters; scientific equipment and instruments, namely, ultra-high vacuum champers and scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; DNA testing apparatus which carry or hold DNA samples for non-medical purposes; Ophthalmic instruments, namely, ophthalmic lenses
5 (Based on 44(e)) Pharmaceutical, medical and veterinary preparations, namely, chemical preparations for pharmaceutical or medical purposes, namely, for treating cancer, medical preparations for the treatment of cancer, pharmaceutical products for the treatment of cancer; medical diagnostic reagents; clinical diagnostic reagents, namely, reagents for use in medical genetic testing; reagents, enzymes, and nucleotides for use in genetic testing for medical and diagnostic purposes, namely, reagents for medical use, diagnostic reagents for medical use, enzymes for medical purposes, reagents for medical use and medical diagnostic reagents, and screening kits comprised of reagents for medical diagnostics and for medical screening use; reagent kits composed of medical diagnostic reagents and medical diagnostic reagent beads with attached biomolecules for clinical diagnostic purposes; diagnostic tests and test kits for determination of genetic information for medical purposes, namely, genetic identity tests comprised of reagents for medical purposes; pharmaceutical products for ophthalmological use, for the treatment of cancer, for treating diabetes, for the treatment of bone disease; diagnostic medical reagents for medical use; medical diagnostic test kits, namely, medical diagnostic preparations and screening kits comprised of reagents for medical diagnostics and medical screening use, diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, namely, cancer
1 (Based on 44(e)) Chemicals used in industry and science; assays and reagents for scientific and research use, namely, assays and reagents for use in genetic research, assays for research purposes, reagents for scientific and research use; diagnostic reagents for scientific use; diagnostic preparations for scientific use; diagnostic test kits for use in the fields of scientific, pharmaceutical and medical research, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; diagnostic test kits for scientific use, namely, kits comprised of diagnostic reagents and preparations for scientific use; chemical reagents for non-medical purposes; chemical test kits for analysis and detection of genetic information and diseases for scientific, clinical or medical laboratory use; chemical reagents and kits containing same, each for scientific purposes; reagents, enzymes, and nucleotides for medical research use; Chemical preparations for pharmaceutical or medical purposes, namely, for chemical additives for use in the manufacture of pharmaceuticals for cancer
10 (Based on 44(e)) Surgical apparatus and instruments for medical use, namely, incubators for medical purposes, apparatus for use in medical analysis, namely, medical diagnostic instruments for the analysis of body fluids; and ophthalmic instruments, namely, lasers for ophthalmic purposes; medical diagnostic apparatus, namely, ultrasonic medical diagnostic apparatus and hematology analyzers for medical diagnostic uses; analytical apparatus for medical purposes, namely, medical instruments for analyzing bacteria and breath gas analyzers for medical diagnostics; medical apparatus for detecting cancer; cholesterol meters; endoscopic equipment for medical purposes; enema apparatus for medical purposes; physical exercise apparatus, for medical purposes; gloves for medical purposes; magnetic resonance imaging apparatus for medical purposes; massage apparatus for medical purposes; medical apparatus and instruments for detecting and treating cancer; DNA testing apparatus which carry or hold DNA samples for medical purposes
TAKE TWO

Trademark Events
Jan 23, 2024
Notice Of Registration Confirmation Emailed
Jan 23, 2024
Notice Of Registration Confirmation Emailed
Jan 23, 2024
Registered-Principal Register
Dec 14, 2023
1(B) Basis Deleted; Proceed To Registration
Nov 14, 2023
Notice Of Allowance Cancelled
Dec 14, 2023
Case Assigned To Intent To Use Paralegal
Nov 14, 2023
Teas Delete 1(B) Basis Received
Nov 14, 2023
Noa E-Mailed - Sou Required From Applicant
Sep 19, 2023
Official Gazette Publication Confirmation E-Mailed
Sep 19, 2023
Published For Opposition
Aug 30, 2023
Notification Of Notice Of Publication E-Mailed
Aug 16, 2023
Case Returned To Examination
Aug 16, 2023
Notice Of Allowance Cancelled
Jul 11, 2023
Noa E-Mailed - Sou Required From Applicant
May 16, 2023
Official Gazette Publication Confirmation E-Mailed
May 16, 2023
Published For Opposition
Apr 26, 2023
Notification Of Notice Of Publication E-Mailed
Apr 10, 2023
Approved For Pub - Principal Register
Mar 15, 2023
Teas/Email Correspondence Entered
Mar 13, 2023
Correspondence Received In Law Office
Mar 13, 2023
Teas Response To Office Action Received
Nov 21, 2022
Notification Of Non-Final Action E-Mailed
Nov 21, 2022
Non-Final Action E-Mailed
Nov 21, 2022
Non-Final Action Written
Oct 26, 2022
Teas/Email Correspondence Entered
Oct 26, 2022
Correspondence Received In Law Office
Oct 25, 2022
Assigned To Lie
Sep 14, 2022
Teas Response To Office Action Received
Mar 22, 2022
Notification Of Non-Final Action E-Mailed
Mar 22, 2022
Non-Final Action E-Mailed
Mar 22, 2022
Non-Final Action Written
Mar 22, 2022
Notification Of Non-Final Action E-Mailed
Mar 22, 2022
Non-Final Action E-Mailed
Mar 22, 2022
Non-Final Action Written
Mar 18, 2022
Assigned To Examiner
Feb 15, 2022
New Application Office Supplied Data Entered
Feb 14, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24